Concepedia
Statistics
Publications
6
Citations
211
H-Index
Active since
2009
Affiliations
Eisai (United Kingdom)(Current)
Health Economics and Outcomes Research (United Kingdom)
United BioSource Corporation (United Kingdom)
Eisai (Japan)
L Verdian is an author at Eisai (United Kingdom) specializing in pharmacoeconomics, pharmacy, and pharmacotherapy.
Publications per year
2009–2014
A Qualitative Investigation of Patients’ and Caregivers’ Experiences of Severe Sepsis*
Katy Gallop, Cicely Kerr, Annabel Nixon et al. · Critical Care Medicine · 2014 · 72 citations
Nursing, Internal Medicine, Communication In Serious Illness +11
Lennox-Gastaut Syndrome (LGS): Development of conceptual models of health-related quality of life (HRQL) for caregivers and children
Katy Gallop, D Wild, L Verdian et al. · Seizure · 2009 · 61 citations · Full text
Pharmacy, Child Health, Pediatrics +15
Cost-utility analysis of rufinamide versus topiramate and lamotrigine for the treatment of children with Lennox–Gastaut Syndrome in the United Kingdom
L Verdian, Yunni Yi · Seizure · 2009 · 26 citations · Full text
Pharmacy, Pharmacoeconomics, Pharmacotherapy +8
The Cost Effectiveness of Rufinamide in the Treatment of Lennox-Gastaut Syndrome in the UK
Ágnes Benedict, L Verdian, Grant Maclaine · PharmacoEconomics · 2010 · 24 citations
Medicine, Pharmacoeconomics, Pharmacology +7
Cost-effectiveness of ziconotide in intrathecal pain management for severe chronic pain patients in the UK
Sarah Dewilde, L Verdian, G. D. H. MacLaine · Current Medical Research and Opinion · 2009 · 18 citations
Pharmacy, Pharmacoeconomics, Pharmacotherapy +17
1–5 of 6